Method of immunoassaying a component to be measured
A method of immunoassaying a component to be measured in a sample containing hemoglobin, which comprises reacting a component to be measured in a sample containing hemoglobin with an antibody capable of binding to the component in the presence of a bile acid derivative different from a bile acid derivative that is inherently contained in the sample; a method of suppressing an interference of hemoglobin in immunoassaying a component to be measured in a sample containing hemoglobin, which comprises reacting a component to be measured in a sample containing hemoglobin with an antibody capable of binding to the component in the presence of a bile acid derivative different from a bile acid derivative that is inherently contained in the sample; a reagent of immunoassay of a component to be measured in a sample containing hemoglobin, which comprises a bile acid derivative, are described.
1. A method of immunoassaying a component to be measured in a sample containing hemoglobin, which comprises:
(i) reacting said component to be measured with an antibody capable of binding to the component in the presence of a bile acid derivative different from a bile acid derivative that is inherently contained in the sample to form an immune complex; and
(ii) determining the amount of the component in the immune complex, wherein the component to be measured is a substance contained within cells or a protein induced within cells by cytokines wherein the bile acid derivative has amphoteric surfactant function or nonionic surfactant function.
2. The method according to claim 1 , which comprises reacting said component to be measured in a sample containing hemoglobin with an antibody capable of binding to the component, further in the presence of a polyoxyethylene nonionic surfactant.
3. The method according to claim 1 or 2 , wherein the method of immunoassay is a sandwich method or a competition method.
4. The method according to claim 1 or 2 , wherein reacting the component with an antibody capable of binding to the component comprises:
(1) reacting the component with a first antibody capable of binding to the component and a labeled second antibody capable of binding to the component,
(2) reacting the component with a labeled competitive substance and an antibody capable of binding to both of the component and the competitive substance, or
(3) reacting the component with a competitive substance and a labeled antibody capable of binding to both of the component and the competitive substance.
5. The method according to claim 1 or 2 , wherein the bile acid derivative different from a bile acid derivative that is inherently contained in the sample is a bile acid derivative having amphoteric surfactant function.
6. The method of claim 1 or 2 , wherein the bile acid derivative different from a bile acid derivative that is inherently contained in the sample is a bile acid derivative having nonionic surfactant function.
7. The method of claim 5 , wherein the bile acid derivative having amphoteric surfactant function is 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate or 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxypropanesulfonate.
8. The method according to claim 6 , wherein the bile acid derivative having nonionic surfactant function is N,N-bis(3-D-gluconamidopropyl)cholamide or N,N-bis(3-D-gluconamidopropyl)deoxycholamide.
9. The method according to claim 2 , wherein the polyoxyethylene nonionic surfactant is polyoxyethylene alkylphenyl ether.
10. The method according to claim 1 or 2 , wherein the sample is whole blood.
11. The method according to claim 1 or 2 , wherein the component to be measured is MxA protein.